Recent Advances in CAR T-Cell Therapy in Lymphoma: Insights from Experts at The John Theurer Cancer Center : Episode 11
Selecting and Sequencing Therapies to Improve Outcomes in Patients With Lymphoma
Key opinion leaders describe when to refer a patient with lymphoma and at what point treatments should be switched, and the evolution of T-cell engaging therapies.
Video Player is loading.
Recent Videos
CAR T in High-Risk DLBCL: Making the Right Choice in Aggressive Disease
PSMA PET Imaging Agents: Image Quality and Diagnostic Performance
Transplant-Eligible, CAR T Considered: How Do We Decide?
The Evolving Role of PSMA PET in Prostate Cancer Imaging and Management
Auto-SCT or CAR T? A Case-Based Discussion in Relapsed DLBCL
Personalizing CAR T: Making the Right Call for Each Patient
Rethinking CAR T Timing: Insights on CAR T Efficacy and Patient Selection
CAR T in the Real World: Clinician Perspectives on Outcomes, Toxicity, and Patient Management
TRANSFORM and ZUMA-7: A Discussion on Efficacy and Safety of CAR T in R/R DLBCL
Tailoring Therapy: Patient-Specific Decision-Making in Relapsed DLBCL
Related Content
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Thomas Habermann, MD;Julie M. Vose, MD, MBA;James R. Cerhan, MD, PhD;Alexandar Tzankov, MD;Andrew D. Zelenetz, MD, PhD
February 17th 2025Podcast
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.
